Replacing Hearts.🔒 SSL Verified
Live Data Status: |News & Media
Welcome to the detailed analysis for bivacor.com. This domain is officially recognized as BiVACOR, Inc. – Replacing Hearts. Restoring Lives.. According to their official web presence, their primary focus is: "Replacing Hearts. Restoring Lives. HEART FAILURE Heart failure is a global epidemic affecting at least 26 million people worldwide, 6.2 million adults in the U.S., and is increasing in prevalence. Heart transplantations are reserved for those with severe heart failure and".
Table of Contents
- Tech Stack
- WordPress
- Link Profile
- Internal Pages: 35Outbound Links: 15
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$716
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- bivacor.comAvailable
- bivacor.netAvailable
- bivacor.orgAvailable
- bivacor.ioAvailable
- bivacor.coAvailable
- bivacor.aiTaken
Official Contact & Profiles
Socials:x.comlinkedin.com
Content Snippets from bivacor.com
"Heart failure is a global epidemic affecting at least 26 million people worldwide, 6.2 million adults in the U.S., and is increasing in prevalence. Heart transplantations are reserved for those with severe heart failure and are limited to fewer than 6,000 procedures per year globally."
"Consequently, the U.S. National Institutes of Health estimated that up to 100,000 patients could immediately benefit from mechanical circulatory support (MCS), and the European market is similarly sized. Without intervention, patients with severe HF have a bleak outlook. For these patients, drug therapy is a limited, relatively ineffective option. Although a heart transplant would meet their needs, only 6000 donor hearts are available globally each year."
"Implantation of a Total Artificial Heart (TAH) is a treatment option for patients with end-stage biventricular HF who need support while on a heart transplant waiting list. Removal of the native ventricles allows the device to completely replace the function of the native heart."
"BiVACOR is conducting an FDA-approved, first-in-human Early Feasibility Study (EFS) to evaluate the safety and performance of the TAH developed by BiVACOR as a bridge-to-transplant solution for patients with severe biventricular or univentricular heart failure in whom left ventricular assist device support is not recommended."
Key Topics & Focus Areas for bivacor.com:
HEART FAILURE
DEVICE
TECHNOLOGY
ABOUT US
MEET THE TEAM
CAREERS
By comparing bivacor.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to bivacor.com.
Frequently Asked Questions
Is bivacor.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of bivacor.com?
As of July 23, 2026, bivacor.com holds an estimated domain authority score of 32/100 based on our VisitRank tracking algorithms.
What are the top alternatives to bivacor.com?
You can find the best alternatives and similar sites to bivacor.com in our explore section, which includes competitors in the News & Media sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for bivacor.com:
bviacor.combiacor.combiivacor.combovacor.combivecor.combivacor.combuvacor.combjvacor.com